The corepressor NCoR1 antagonizes PGC-1α and estrogen-related receptor α in the regulation of skeletal muscle function and oxidative metabolism

Molecular and Cellular Biology

Volumn 32, Issue 24, 2012, Pages 4913-4924

  Pérez Schindler, Joaquín ^a   Summermatter, Serge ^a   Salatino, Silvia ^a   Zorzato, Francesco ^b,c   Beer, Markus ^a   Balwierz, Piotr J ^a,d   Nimwegen, Erik van ^a,d   Feige, Jérôme N ^e,f   Auwerx, Johan ^f   Handschin, Christoph ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF FERRARA   (Italy)

^d Swiss Institute of Bioinformatics   (Swaziland)

^e Novartis Institute for Biomedical Research   (Swaziland)

^f EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RECEPTOR INTERACTING PROTEIN 140;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATIGUE; GENE EXPRESSION; MALE; METABOLIC DISORDER; MOUSE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SKELETAL MUSCLE;

MUS;

EID: 84871902783     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00877-12     Document Type: Article

References (52)

1. Alenghat T, et al. 2008. Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature 456:997-1000.
2. Al-Shahrour F, Diaz-Uriarte R, Dopazo J. 2004. FatiGO: a web tool for finding significant associations of gene ontology terms with groups of genes. Bioinformatics 20:578-580.
3. Baar K. 2010. Epigenetic control of skeletal muscle fibre type. Acta Physiol. 199:477-487.
4. Baar K, et al. 2002. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J. 16:1879-1886.
5. Bailey P, et al. 1999. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD. Mol. Endocrinol. 13:1155-1168.
6. Barres R, et al. 2012. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 15:405-411.
7. Bassel-Duby R, Olson EN. 2006. Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem. 75:19-37.
8. Booth FW, Lees SJ. 2007. Fundamental questions about genes, inactivity, and chronic diseases. Physiol. Genomics 28:146-157.
9. Booth FW, Roberts CK. 2008. Linking performance and chronic disease risk: indices of physical performance are surrogates for health. Br. J. Sports Med. 42:950-952.
10. Busson M, et al. 2005. Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. Oncogene 24:1698-1710.
11. Calvo JA, et al. 2008. Muscle-specific expression of PPARgamma coactivator- 1alpha improves exercise performance and increases peak oxygen uptake. J. Appl. Physiol. 104:1304-1312.
12. Charest-Marcotte A, et al. 2010. The homeobox protein Prox1 is a negative modulator of ERRα/PGC-1α bioenergetic functions. Genes Dev. 24:537-542.
13. Ehrenborg E, Krook A. 2009. Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta. Pharmacol. Rev. 61:373-393.
14. Fischle W, et al. 2002. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/ N-CoR. Mol. Cell 9:45-57.
15. Furuya F, et al. 2007. Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling. Mol. Cell. Biol. 27:6116-6126.
16. Giguere V. 2008. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr. Rev. 29:677-696.
17. Glass CK, Rosenfeld MG. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:121-141.
18. Gonzalez E, Delbono O. 2001. Age-dependent fatigue in single intact fast and slow fibers from mouse EDL and soleus skeletal muscles. Mech. Ageing Dev. 122:1019-1032.
19. Handschin C, Spiegelman BM. 2008. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 454:463-469.
20. Hardie DG, Ross FA, Hawley SA. 2012. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13: 251-262.
21. Hawley SA, et al. 2012. The ancient drug salicylate directly activates AMP-activated protein kinase. Science 336:918-922.
22. Horlein AJ, et al. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
23. Ishizuka T, Lazar MA. 2005. The nuclear receptor corepressor deacetylase activating domain is essential for repression by thyroid hormone receptor. Mol. Endocrinol. 19:1443-1451.
24. Jepsen K, et al. 2000. Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 102:753-763.
25. Kelley DE, He J, Menshikova EV, Ritov VB. 2002. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944-2950.
26. Kitamura T, et al. 2007. A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J. Clin. Investig. 117:2477-2485.
27. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128:693-705.
28. Li P, et al. 2011. Adipocyte NCoR knockout decreases PPARgamma phosphorylation and enhances PPARgamma activity and insulin sensitivity. Cell 147:815-826.
29. Lin J, Handschin C, Spiegelman BM. 2005. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1:361-370.
30. Lin J, et al. 2002. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418:797-801.
31. McGee SL, Hargreaves M. 2011. Histone modifications and exercise adaptations. J. Appl. Physiol. 110:258-263.
32. McKenna NJ, O'Malley BW. 2010. SnapShot: NR coregulators. Cell 143: 172-172.e1. doi:10.1016/j.cell.2010.09.032.
33. Mootha VK, et al. 2004. Erralpha and Gabpa/b specify PGC-1alphadependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl. Acad. Sci. U. S. A. 101:6570-6575.
34. Mootha VK, et al. 2003. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34:267-273.
35. Nuutila P, et al. 1994. Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle. J. Clin. Investig. 93:2267-2274.
36. Oka S, et al. 2011. PPARalpha-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway. Cell Metab. 14:598-611.
37. Perissi V, Aggarwal A, Glass CK, Rose DW, Rosenfeld MG. 2004. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116:511-526.
38. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. 2004. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350:664-671.
39. Potthoff MJ, et al. 2007. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J. Clin. Investig. 117:2459-2467.
40. Reilly SM, et al. 2010. Nuclear receptor corepressor SMRT regulates mitochondrial oxidative metabolism and mediates aging-related metabolic deterioration. Cell Metab. 12:643-653.
41. Santos GM, Fairall L, Schwabe JW. 2011. Negative regulation by nuclear receptors: a plethora of mechanisms. Trends Endocrinol. Metab. 22:87-93.
42. Schuler MJ, Buhler S, Pette D. 1999. Effects of contractile activity and hypothyroidism on nuclear hormone receptormRNAisoforms in rat skeletal muscle. Eur. J. Biochem. 264:982-988.
43. Schuler MJ, Pette D. 1998. Quantification of thyroid hormone receptor isoforms, 9-cis retinoic acid receptor gamma, and nuclear receptor corepressor by reverse-transcriptase PCR in maturing and adult skeletal muscles of rat. Eur. J. Biochem. 257:607-614.
44. Shearer BG, et al. 2008. Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist. Mol. Endocrinol. 22:523-529.
45. Summermatter S, et al. 2012. Remodeling of calcium handling in skeletal muscle through PGC-1alpha: impact on force, fatigability, and fiber type. Am. J. Physiol. Cell Physiol. 302:C88-C99.
46. Sutanto MM, et al. 2010. The silencing mediator of retinoid and thyroid hormone receptors (SMRT) regulates adipose tissue accumulation and adipocyte insulin sensitivity in vivo. J. Biol. Chem. 285:18485-18495.
47. Suzuki H, et al. 2009. The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat. Genet. 41:553-562.
48. Webb P, et al. 2000. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol. Endocrinol. 14:1976-1985.
49. Willy PJ, et al. 2004. Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand. Proc. Natl. Acad. Sci. U. S. A. 101:8912-8917.
50. Wisloff U, et al. 2005. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 307:418-420.
51. Yamamoto H, et al. 2011. NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell 147:827-839.
52. Yoon HG, et al. 2003. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 22:1336-1346.